C4Diagnostics enables hospital and city laboratories to perform culture-based diagnostic tests, faster and more sensitive, thanks to specific fluorescence. C4Diagnostics is developing in vitro diagnostics kits based on its proprietary technology.
Biopharma, Biotechnology, Medical Device
Between €2.5 million-5 million
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as C4Diagnostics? We’re happy to assist you with our Startup Sourcing service.